Author/Authors :
Buğan, Barış Cleveland Clinic - Department of Cardiovascular Medicine, USA , Kapadia, Samir R. Cleveland Clinic - Department of Cardiovascular Medicine, USA , Tuzcu, E. Murat Cleveland Clinic - Department of Cardiovascular Medicine, USA
Abstract :
Several reports have shown that up to 70% of all transcatheter aortic valve replacement (TAVR) patients suffer from paravalvuler aortic regurgitation (AR). In approximately 15% of the patients AR is graded as moderate or severe (1, 2).
